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Purpose: Atheroembolization may cause limb loss or organ failure. Surgical outcome data 
are limited. We report the largest series of atheroembolization f cusing on patterns of 
disease, surgical treatment and outcome. 
Methods: One hundred patients (70 men), mean age 62 +- 11 years, operated on for lower 
extremity, visceral, or nonthoracic outlet upper extremity atheroemboli were identified 
prospectively and monitored over a 12-year period. The atheroembolic source was 
localized by use of a combination of computed tomography scanning (n = 55), 
arteriography (n = 93), duplex scanning (n = 25), transesophageal echocardiography 
(n = 6), and magnetic resonance imaging (n = 4). Occlusive aortoiliac disease (47 
patients) and small aortic aneurysms (20 patients; mean aneurysm size 3.5 + 0.8 cm) were 
the most ,c~176 source of atheroemboli. Imaging studies revealed 12 patients with 
extensive suprarenal ortic thrombus. Correction of the embolic source was achieved with 
aortic bypass (n = 52), aortoiliacendarterectomy and patch (n = 11), femoral or popliteal 
endarterectomy and patch (n = 11), infrainguinal bypass (n = 3), extraanatomic recon- 
struction (n = 6), graft revision (n = 3), upper extremity bypass (n = 11), or upper 
extremity endarterectomy and patch (n = 3). 
Results: All four deaths within 30 days and all seven deaths within the first 6 months after 
survival probabilities for all patients at 1, 3, and 5 years were 89%, 83%, and 73%, 
respectively. After operation, nine patients required major leg amputations and 10 
required toe amputations. Renal atheroemboli ed to hemodialysis in 10 patents. 
Recurrent embolic events occurred in five of 97 patients monitored for a mean of 32 
months. All five recurrences occurred in the first 8 months after operation. Three patients 
with recurrent emboli had suprarenal aortic disease, one of whom had undergone 
axillofemorofemoral bypass. Four o f  15 patients receiving postoperative warfarin 
anticoagulation had development of recurrent embolism. Only one patient not receiving 
postoperative warfarin had a recurrent event (p < 0.05 by Fisher exact est). 
Conclusion: The atheroembolic source is the aorta or iliac arteries in two thirds of patients 
mortality or limb loss rates except when the suprarenal orta is involved. (J VASC SURG 
1995;21:773-81.) 
The reported natural history of  atheroemboliza- 
tion emphasizes a high rateof  bo~ recurrene mbolic 
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episodes and tissue loss. An 80% recurrence rate 
( fo~ of  five patients) and 60% incidence of tissue loss 
(three of five patients) were documented for infrain- 
guinal atherosclerofic embolic sources that were not 
corrected by operati0ni t Compounding the problem, 
medical management of atheroembolization, usually 
Consisting of aspirin or warfarin, has resulted in a 
75% recurrence rate. z This generally poor outcome 
for patients who are treated without surgery 
prompted an aggressive approach toward identifying 
and, where possible, operating to correct he source 
of the emboli. The most common source of athero- 
emboli, either aortoiliac or infrainguinal, has been 
debated. 1,3 The relative infrequency with which 
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atheroembolism is diagnosed and the dependence on 
arteriography alone to locate the atheroembolic 
source 4 has limited the ability of prior reports to 
determine accurately the most common embolic 
source. The most frequent argets of atheroembolic 
events have also not been detailed. 
Operative interventions to treat atheroembolic 
sources include direct arterial replacement with 
prosthetic or autogenous bypass grafts, s local endar- 
terectomy and patch angioplasty, 1,a and extraana- 
tomic arterial reconstruction with exclusion of the 
proximal source .  6'7 In this series the results of the 
surgical treatment of atheroembolization at one 
institution over a recent 12-year period are reported, 
including sources, targets, and operations. 
PATIENTS AND METHODS 
A total of 141 patients with either upper or lower 
extremity atheroembolization from a noncardiac 
source were identified prospectively between Sep- 
tember 1982 and June 1994 at Northwestern Uni- 
versity Medical Center. Of these 141 patients, 116 
patients underwent vascular operations to correct he 
arterial source of the embolic events, and 25 patients 
did not-because of medical unfitness or refusal. 
Among the 116 patients who underwent operative 
procedures, 86 patients had surgery for visceral and 
lower extremity atheroembolization, a d 30 patients 
had surgery for upper extremity emboli. The majority 
of patients who sustained upper extremity atheroem- 
bolization, 16 of 30, were found to have arterial 
complications of the thoracic outlet syndrome and 
are reported in a separate study. 8The remaining 100 
patients who underwent operations to treat an 
atheroembolic source, including 14 patients with 
nonthoracic outlet upper extremity atheroembolic 
events and 86 patients with lower extremit3~ or 
visceral atheroembolic events, are the focus of this 
study. Patients diagnosed with iatrogenic emboliza- 
tion after an open vascular operation were excluded 
from this review unless atheroembolization had also 
occurred before the operation. 
The patients examined included 70 men (70%) 
and 30 women. Their ages ranged from 32 to 90, 
with a mean of 62 _+ 11 years. Seventy-four patients 
(74%) had a history of smoking, 46 patients (46%) 
had hypertension, and 22 patients (22%) had diabe- 
tes mellitus. 
Significant preexisting peripheral vascular disease 
was noted in 27 patients (27%), significant coronary 
artery disease was present in 34 patients (34%), 
including 16 patients who had undergone prior 
coronary artery bypass grafting. Collagen vascular 
disease was found in five patients who were all 
receiving prednisone at the time of their embolic 
events. Prior arterial embolectomy had been per- 
formed in seven patients. 
Associated or precipitating factors for embolic 
events included use of warfarin in 21 patients, 
arteriography in 17 patients, percutaneous translu- 
minal angiography in five patients, trauma in five 
patients, and laparotomy in three patients. Indica- 
tions for warfarin use included heart disease, history 
of deep venous thrombi, and failed vascular grafts. 
No associated or precipitating factors were recog- 
nized in 49 patients. 
The diagnosis of atheroembolization was made 
on the basis of characteristic clinical findings, which 
included acute lower extremity ischemia, livedo 
reticularis, or painful blue toes or fingers. Noninva- 
sive arterial Doppler studies were used to confirm 
extremity or digital ischemia. The type of emboli 
were identified as macroemboli (those occluding a 
named artery) or microemboli. 9 Macroemboli oc- 
curred in 39 patients (39%). Isolated microemboli, 
presenting as blue toes or fingers or livedo reticularis, 
occurred in 45 patients (45%). Manifestations of 
both macroembolization and microembolization 
were seen in 17 patients (17%). Eleven patients 
(11%) had renal atheroemboli and resulting renal 
insufficiency, 10 of whom required at least emporary 
hemodialysis. The target locations of atheroemboli in 
these 100 pat!ents are shown. (Fig. 1). 
The diagnosis of atheroemboli was supported by 
localization of a proximal, noncardiac arterial source 
of the emboli. Diagnostic tests used in these patients 
included angiography in 93 patients, computed 
tomography (CT) scanning of the aorta in 55 
patients, duplex scanning in 25 patients, transesoph- 
ageal echocardiography in six patients, and magnetic 
resonance imaging (MR/) in four patients. Twelve 
patients were found on CT scanning to have extensive 
suprarenal aortic thrombus. 
The atheroembolic source (Fig. 2) was identified 
as aortoiliac stenosis in 47 patients, aortoiliac aneu- 
rysm in 20 patients (Fig. 3), lower extremity stenosis 
in 10 patients (Fig. 4), lower extremity aneurysm in 
two patients, upper extremity arterial stenosis in six 
patients (Fig. 5), nonthoracic outlet upper extremity 
aneurysm in eight patients, or anastomotic pseudo- 
aneurysm in seven patients. 
The infrarenal aorta was the most common source 
of emboli, and aortic operations were the most 
common procedures performed. Three distinct pat- 
terns of aortic iliac disease were observed: aortoiliac 
occlusive disease, small aortic aneurysms without 
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Fig. 1. PreSenting targets Of atheroembolic events in i00 
patients treated with operation directly at source of 
atheroemboli. 
Fig. 2. Source o f  atheroemboli n 100 patients 
treated with operation tmdertaken to eliminate source of 
embolL 
aneurysmal involvement of the iliac arteries, and 
small aortic aneurysms with iliac occlusive disease. 
The mean size of aortic aneurysms was 3.5 - 0.8 cm. 
Only one aortic aneurysm of the 20 identified as the 
embolic source was larger than 4.5 cm. 
The operative procedure was tailored to eliminate 
the embolic source. Endarterectomy and patch an- 
gioplasty was performed for localized disease. Oth- 
erwise, bypass was performed. Aortic operations 
were required in 57  patients. These included 26 
patients with aortofemoral bypass, 10 patients with 
aortoiliac bypass, 16 patients with aortic tube bypass, 
and 5 patients with aortic endarterectomy and patch 
angioplasty. Isolated iliac occlusive disease (Fig. 6) 
was treated by endarterectomy and patch angioplasty 
in six patients. Infrainguinal reconstructions were 
performed in 17 patients. These operations include 
common femoral artery endarterectomy and patch 
angioplasty in four patients, superficial femoral or 
popliteal artery endarterectomy and patch angio- 
plasty in seven patients, repair ofpseudoaneurysms in 
three panents, and femoropopliteal or femorotibial 
bypass in three patients. Both autogenous and 
prosthetic grafts and patches were used for infrain- 
guinal reconstructions. Extraanatomic reconstruc- 
tions were performed in six patients. Axillofemoro- 
femoral bypasses were used in three patients, and 
femorofemoral bypasses were completed in three. 
Upper extremity bypass was performed in 11 pa- 
tients, and endarterectomy and patch angioplasty was 
undertaken i : three patients. Overall, 78% of em- 
bolic lesions were treated with a bypass operation, 
and 22% were treated with local endarterectomy and 
patch angioplasty. 
RESULTS 
The 30-day mortality rate was 4%. Seven 
operative-related deaths occurred in the first 6 
months after operation. The deaths occurred on 
postoperative days 2, 14, 22, 26, 49, 120, and 133. 
Aortic operations had a 6-month mortality rate of 7% 
(four of 57 patients). Extraanatomic reconstructions 
had a 6-month mortality rate of 33% (two of six 
patients). Iliac operations had a &month mortality 
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Fig. 3. Star-shaped thrombus in small (3.7 cm) abdominal aortic aneurysm that presented with 
embolization, leading to transmetatarsal and above-knee amputation. Characteristic operative 
findings in aneurysms that embolized was irregular, complex thrombus overlying ulcerative 
aortic plaque. 
Fig. 4. Characteristic superficial femoral artery atheroem- 
bolic lesion responsible for '~ toe syndrome." 
rate of 17% (one of six patients). None of the patients 
undergoing infrainguinal reconstructions died. In all, 
three patients were lost to  follow-up, leaving 97 
patients available for follow-up at a mean length of 32 
months. The cumulative survival probabilities were 
89% at 1 year, 83% at 3 years, and 73% at 5 years 
(Fig. 7). All seven early deaths occurred in the group 
of 12 patients who had major suprarenal aortic 
thrombus present on preoperative CT scanning. 
Renal atheroembolization requiring hemodialysis 
contributed to he perioperative death of six of these 
seven patients. Recurrent massive mbolization on 
postoperative day 22 led to the death of a seventh 
patient who had undergone axillofemorofemoral 
bypass. 
Major morbidity included kidney failure, intra- 
operative mboli, and limb loss. Renal atheroemboli 
occurred before operation in l l  patients (11%) 
leading to at least temporary hemodialysis in 10 
patients (10%). Myoglobin release related to muscle 
emboli, although never clinically apparent, could 
have contributed to the observed kidney failure in 
some cases. Intraoperative embolic events occurred in 
seven patients (7%), and lead to deterioration ofrenal 
function in three patients. Over the entire series 
major leg amputations were required in nine patients, 
and toe amputations were required in 10 patients in 
the postoperative p riod. 
Recurrent emboli occurred after operation in five 
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Fig. 6. Common iliac artery stenosis that presented as 
livedo reticularis. 
Fig. 5. Proximal left subclavian stenosis that presented 
with microemboli to fingers. 
patients (5%). The interval:between operation and 
recurrence was 1 month in two patientss 2 months in 
one patient, 6 months in one patient, and 8 months 
in one patient. Among the patients with recurrent 
emboli, three patients had undergone aortofemoral 
or aortoiliac reconstruction and had residual supra- 
renal aortic disease. The suprarenal disease was 
characterized on CT scanning by irregular, shaggy 
thrombus in a normal diameter:aorta. One patient 
who had undergone axillofemoral bypass had recur- 
rent emboli to more proximal targets and died on 
postoperative day 22 as described above. One patient 
who underwent i!iac endarterectomy ha d emboliza- 
tion from a more proximal aortic disease: 
Among the five patients who had recurrent 
embolic episodes, four were given warfarin (Cou- 
madin) at the time of the recurrence. Eleven patients 
given Coumadin after operation did not have de- 
velopment of recurrent embolic episodes. Only one 
o f  the 82 patients (data not available on three 
patients lost to follow-up) not receiving warfarin 
after the operation had lrecurrent emboli events. 
Interestingly, warfarin anticoagulation was signifi- 
cantly associated with recurrent emboli (by Fisher's 
exact test, p < 0.05). One patient who had a 
recurrent embolic episode was not receiving war- 
farin after operation. He had been receiving war- 
farin before his initial operation but was not in the 
postoperatwe period. 
DISCUSSION 
The hypothesis that embolic diseasc may origi- 
nate from diseased atherosderotic aorta was 
first made by  Flory 1~ in 1944. He observed a 
positive correlation bctween the number of vis- 
ceral: and musculature atheroemboli in human au- 
topsy specimens and the extent of thoracic and 
abdominal aortic atherosclerosis. Flory 1~ tested this 
hypothesis by dissolving and injecting atheroscle- 
rotic plaque into rabbit ear veins, producing analo- 
gous embolic lesions in the rabbit pulmonary tissue. 
The diagnosis of digital gangrene and livedo re- 
ticularis caused by microemboli was first made by 
Hoye et al. n in 1959. The Surgical treatment of 
the source of atheroemboli followed in 1967, 
when Crane ~2 replaced a diseased aortoiliac segment 
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Fig. 7. Cumulative survival probabilities for patients who underwent operation to treat source 
of atheroemboli. Ninety-seven patients were available for follow-up at mean of 32 months. 
Survival probabilities were 89% + 4%, 83% +- 5%, and 73% +- 7% at 1, 3, and 5 years, 
respectively. 
that had caused microemboli to the lower ex- 
tremities. Because of the poor outcome attributed 
to nonsurgical treatment in these patients, opera- 
tion has become a recognized therapy. This report 
is the largest series to date examining atheroem- 
bolization and focusing on patterns of disease and 
outcome. 
Aortoiliac disease was by far the most common 
source of atheroemboli and accounted for more than 
75% of the cases to the lower extremity and 67% 
overall. The finding that the largest percentage of 
atheroemboli originates in aortoiliac segments i in 
contrast to reports by Karmondy et al., ~ who 
observed 23 of 31 patients (74%) with infralnguinal 
sources .  
The imaging studies used to localize the embolic 
sources have evolved in recent years as we have 
recognized the frequency with which the thoracic and 
abdominal aorta contribute to these events. Our 
trend has been to depend more on CT scanning and 
less on arteriography. 9 I fa patient was admitted with 
a pulse deficit consistent with macroemboli, aor- 
toiliac angiography was considered an essential test. 
In our series, 93 of 100 patients (93%) who 
underwent operation had been studied with arteri- 
ography. 
For patients with microembolization and no 
pulse deficit, evaluation began by performing CT 
scanning of the abdominal and thoracic aorta as the 
initial imaging study, is CT scanning provides everal 
advantages compared with aortography, which car- 
ties a real risk of causing further embolic events at the 
time of procedure, 14particularly if the catheter is 
passed through an aneurysm. Arteriography had 
been associated with embolic events in 17 of the 
patients (17%) who eventually underwent operation 
designed to alleviate the source of the embolus. I f  the 
source of the emboli can be adequately identified and 
delineated noninvasively without triggering further 
atheroembolization, thepatient will be better served. 
Infusion CT scanning provides good visualization of 
intraluminal thrombus and plaque in the abdominal 
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and thoracic aorta. CT scanning can readily demon- 
strate the characteristic appearance of the star-shaped 
thrombus within small aneurysms (Fig. 3) that are 
most likely to embolize, is
CT imaging of the entire abdominal aorta is 
important to identify those patients at the highest risk 
for poor operative outcomes. If irregular atheroscle- 
rotic disease extends above the level of the renal 
arteries, the operative risk and recurrence risk in the 
present series was high. If the contrast bolus was not 
properly timed, this pathologic finding could be 
missed. Often, separate infusion CT scanning had to 
be performed to completely evaluate the thoracic and 
abdominal aorta. 
Operations can be performed on the vast ma- 
jority of patients with atheroemboli with low i overall 
mortality rates. However, patients have a higher isk 
if they have a shaggy aorta-extensive atheroscte- 
rosis and intraluminal thrombus that extends proxi- 
mally to the suprarenal abdominal aorta o r  the 
descendin thoracic aorta i6,17 The hi her morbidi g ....... ~ .... g .... ~ .... ty 
and mortality rates in this group of patients appear 
relatedto the risk of visceral and renal atheroemboli 
in addition to lower extremitv emboli. Renal athe- 
roemboli contributed to Six of seven early deaths in 
this series. 
We recognized retrospectively the significance of 
suprarenal ortic thrombus. We now carefully evalu- 
ate both the thoracic and Upper abdominal aorta in 
addition to the infrarenal-aorta with preoperative CT 
scanning, MRI or transesophageal aortic imaging. 
Transesophageal chocardiography and MRI can be 
performed to confirm disease in the thoracic and 
abdominal aorta and also have the advantage of not 
reqmring the use of intravenous contrast. 
The poor outcome observed in panents under- 
going repair of the infrarenal aorta in the setting of 
additional suprarenal ortic disease suggests the need 
to completely eliminate both the suprarenal and 
infrarenal aortic source if direct repair is undertaken. 
The recurrent emboli also appeared related to re- 
sidual aortic disease. Whether suprarenal aorta 
thromboendarterectomy, grafting, extraanatomic re- 
construction, or observation has the best long-term 
outcome for this group of patients with extensive 
disease is not known. 
Seven patients ustained intraoperative emboli. 
Irregular plaque or thrombus at the juxtarenal aorta 
can fragment and embolize at the time of operative 
clamp placement. Supraceliac lamp placement as 
opposed to infrarenal or suprarenal clamping can be 
used to minimize this problem in selected patients on 
the basis of CT findings. 18 Additional operative 
techniques to reduce intraoperative mbolization 
include distal clamping before proximal clamping, 
temporary renal artery clamping before proximal 
aortic clamping, extensive irrigation with heparin 
saline solution, and flushing of inflow and backbleed- 
ing of the outflow before completing each anasto- 
mosis, t319 Ten percent of patients (nine of 86) 
required leg amputation and 11% required minor 
amputations. The vast majority of the amputations 
were due to emboli events that occurred before 
operative intervention. 
Twenty-five patients with atheroemboli d d not 
undergo peration, either because they were believed 
to be medically unfit or because they refused opera- 
tion. Extraanatomic reconstruction may provide 
some protection from future atheroembolic events in 
the majority i3f these patients, even in the setting of 
visceral emboli. 6'7 However, one of our patients who 
had undergone xtraanatomic reconstruction did 
sustain recurrent visceral emboli. 
Antico~i~ation with warfarin does not control 
atheroemboiization a d may actually aggravate the 
condition.20; 21 Although we observed a statistical 
association between warfarin use and recurrence, this 
finding does not necessarily mean warfarin causes 
recurrent emboli because a selection bias may exist. 
Patients with residual disease were those most likely 
to be given warfarin after operative intervention. 
However, our findings certainly do not promote the 
use of warfarin in patients with atheroembolization. 2 
In summary, sources of atheroemboli can be 
eliminated siargicaUy with low morbidity, recurrence, 
and limb loss, except when the suprarenal aorta is 
involved. Good long-term survival (73% at 5 years) 
can be expected after operative intervention. 
We appreciate he assistance ofRael Slavinsky, RN, in 
data analysis and Lynnette Dangerfield and Lisa Shogren in 
preparation of the manuscrtpt. 
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D ISCUSSION 
Dr. Marian McNamara (Indianapolis, Ind.). Ulcer- 
ated atherosclerotic plaque is a common finding in both 
aneurysmal nd occlusive aortic disease. Although ulcer- 
ated atheromas are very commonly visualized uring aortic 
surgical procedures, the preoperative identification ofdistal 
emboli s rare in comparison. 
Two groups of patients with atheroembolization are 
recognized. Those who have spontaneous embolism and 
those whose embolisms occur after instrumentation for 
arteriography, cardiac atheterization, or surgical interven- 
tion. The recurrence rates are reported to be high for 
spontaneous embolization. The natural history of athero- 
embolization after instrumentation is not as well docu- 
mented. 
DiagnOsis is also problematic. Arteriography, CT 
scanning, and transesophageal echocardiography easily 
identify atherosclerotic plaque, frequently at multiple 
levels. None of these studies localizes the symptomatic 
ulcerated plaque that caused the distal embolus. The choice 
of surgical procedure therefore isbased on the premise that 
the symptomatic area is located in the most diseased 
segment, usually the infrarenal aorta. 
Operative intervention is successful in preventing 
recurrent emboli when the embolic focus is located in the 
infrarenal aorta. Dr. Keen and his colleagues have shown 
that the recurrence rate was only 5 in 97 patients monitored 
for greater than 30 months. Three of these patients had 
suprarenal disease. 
In patients with suprarenal nd thoracic aortic disease, 
operative intervention is rarely possible. It is our experience 
that these patients have a high mortality rate because of 
renal and mesenteric nfarction. Warfarin and antiplatelet 
agents have been suggested to decrease recurrence in this 
group. The authors, however, point out a high recurrence 
rate with warfarin management (4 of 15 patients). 
Do you evaluate the entire aorta from the left subcla- 
vian to the bifurcation i  patients with atheroembolization? 
Do you believe that warfarin provides any protection for 
patients who are not candidates for operative intervention? 
Your study states that recurrent embolization was more 
common in patients receiving warfarin than in those not 
receiving the drug. How were patients elected to receive 
the drug? You also list Coumadin as a precipitating cause 
for embolization. Do you believe that warfarin is contrain- 
dicated in the treatment of atheroembolization? Do you 
believe there is a difference in risk and outcome in patients 
having embolization after instrumentation f  the aorta for 
cardiac catheterization r aortography versus those with 
spontaneous occurrence of ernboli? 
Dr. Richard R. Keen. In terms of the most common 
source, we were impressed that it seemed that the infrarenal 
aorta was the most common source of emboli. As a result, 
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most of these patients could be treated well with operation, 
if the disease seems to be limited to that location. We 
usually perform CT scanning first if we have any evidence 
of disease of the aorta, with the reason being that if there 
was extensive disease all the way up to the subclavian artery, 
that would temper our enthusiasm for offering operative 
intervention tothese patients. Accordingly transesophageal 
echocardiography (TEE) would be very important because 
sometimes that would give a dynamic study of these 
patients, and there were cases where you could actually see 
the plaque flapping with each cardiac pulsation in the aorta. 
Sometimes we emphasize studying the abdominal aorta 
first with CT, and it's difficult o view both the thoracic and 
the abdominal aorta with one bolus. Sometimes a patient 
will require an additional study to evaluate the thoracic 
aorta proximally with CT, and that's a case where TEE or 
MRI scanning could be helpful if a patient has underlying 
renal insufficiency. 
In terms of using warfarin, there was probably a 
selection bias in our patients in that a patient who had an 
isolated iliac plaque and was treated with endarterectomy 
would probably not be put on warfarin therapy. However, 
patients who had multiple pisodes of atheroembolization 
because they might have some underlying ischemia were 
probably the' ones who were put on warfarin therapy, so we 
can probably say from our results that, although warfarin 
was positively associated with recurrence, it doesn't neces- 
sarily mean that the warfarin caused recurrence. All we can 
say is that warfarin does not appear to provide sure 
protective ffect in terms of preventing future embolic 
episodes. 
With regard to why warfarin may trigger this problem, 
it may be related to stabilization of the plaque or the 
thrombus overlying the ulcerated aorta. If  warfarin does 
contribute to the atheroembolization one cause may be that 
the fibrin cap has more difficulty forming in the setting of 
warfarin. That would be strictly speculation. 
Dr. Donald P. Spadone (Columbia, Mo.). It may be 
possible to determine which plaque is causing atheroem- 
bolization in a patient with mild, diffuse disease of the iliac, 
superficial femoral, and popliteal arteries by use of angi- 
ography. We have used color Doppler ultrasonography to 
identify the responsible sion. A hemorrhagic plaque, seen 
on ultrasound imaging as a complex echolucent structure, 
is usually the lesion that caused the embolization. Have you 
used ultrasonography to screen your patients to identify the 
plaque responsible for their symptoms? 
Dr. Keen. We found that high-grade stenoses were a 
common characteristic that you can pick up with the 
velocity on duplex scanning. We found that very helpful for 
the iliac lesions and anything further down. 
Dr. Thomas Cogbill (LaCrosse, Wis.). We've had 
extensive xperience treating patients with visceral athero- 
embolization. The diagnosis in these patients is not always 
easy because you don't want to put them through many 
invasive diagnostic tests, nor can they really tolerate a dye 
load if they have renal insufficiency. We have found two 
tests that are helpful. One is renal biopsy and the other is 
gastrocnemius muscle biopsy performed with the patient 
under local anesthesia to help make the diagnosis. Do you 
have any experience using either of these techniques? 
Dr. Keen. We did not use either of those techniques 
before operation. It's a clinical diagnosis that is underrec- 
ognized, but you can make the diagnosis on the basis of 
those clinical findings with correlation of a proximal source. 
Dr. McLaughlin (Lakewood). What are your recom- 
mendations for preserving the tissue distal to the ischemic 
event once you have anatomically corrected the lesion? In 
other words, how do you preserve the digits after you have 
revascularized the limb? 
Dr. Keen. We did not perform any additional proce- 
dures. Lumbar sympathectomy has been reported in the 
past as helpful with atheroembolization, but we did 
nothing else in addition. If a patient was not gwen 
Coumadin, we would give patients aspirin as we would 
most patients undergoing vascular surgery, but there were 
no other adjunctive measures that we would use. We 
attempted to make it a curative resection, and that was the 
best treatment. 
